<DOC>
	<DOCNO>NCT01162304</DOCNO>
	<brief_summary>The investigator hypothesize subject great pain relief take IR-oxycodone compare ER-oxycodone several reason . The ability take varying amount medication six different point course day allow patient take much ( little ) medication need control pain . In addition , ability vary medication dose way give great sense control , also contribute great pain relief . Similarly , investigator predict patient show great benefit IR-oxycodone measure physical emotional functioning . Because relatively little data sleep apnea chronic pain patient ( Webster et al. , 2008 ) , assessments exploratory hypothesis-based . Finally , although typically think abuse liability IR-opioid medication great ER-medications , data belief base involve systematic study patient chronic pain ; assessment abuse liability therefore also exploratory .</brief_summary>
	<brief_title>Open-Label Trial Comparing Oxycodone Medications</brief_title>
	<detailed_description>This study single-center , randomize , open-label , 13-week , 2-period crossover clinical trial . Subjects complete follow ( unless withdraw trial ) : ( 1 ) one-week baseline period subject complete pain diary remain stable dosage exist pain medication ; ( 2 ) immediate-release ( IR ) oxycodone 5 mg 3-4 pill every four hour ; ( 3 ) extended-release ( ER ) oxycodone 40 mg 1 pill every 12 hour IR-oxycodone 5 mg 1-2 pill every six hour . Subjects randomize one two treatment sequence ( ER-oxycodone first IR-oxycodone vice verse ) . It expect trial take approximately 2 year complete . Crossover period . Each two treatment period 6 week duration , allow ample time ass pain relief , adverse effect , treatment satisfaction , impact treatment health-related quality life . There need titration period begin either period washout period second period oxycodone dosage administer period . At visit , subject give sufficient medication sustain least follow visit .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>1 . Be least 18 year old . 2 . Be able read understand English . 3 . Have diagnose chronic pain condition pain every day day previous 6 month . 4 . Be receive equivalent 40120 mg daily opioid analgesic safely convert oxycodone ; dosage include use opioid analgesic , include `` rescue '' `` breakthrough '' pain . 5 . Have average daily pain rating baseline week pain rating equal 4.0 great 010 numerical pain rating scale ( NRS ) average pain intensity past 24 hour . 6 . Have complete least 6 7 daily diary baseline week . 7 . Have least 5 baseline week pain diary rating equal 3 great 010 NRS , one rating 9 rating 10 . 8 . Have stable concomitant use painrelated medication 8 week prior screen willing continue stable use medication duration trial . 9 . Have ability either independently accompany person come research center study visit . 1 . Treatment chronic pain nerve block interventional procedure within past 8 week . 2 . A Beck Depression Inventory score &lt; 27 baseline clinically significant depression dementia , opinion investigator , may interfere subject ' adherence study protocol and/or accurate consistent reporting pain . 3 . History suicide attempt within past 2 year current suicide plan intent . 4 . History excessive alcohol use illicit drug use within past 2 year . 5 . Lack adequate birth control premenopausal woman childbearing age and/or positive urine pregnancy test , perform woman except &gt; 2 year postmenopausal hysterectomy ) . 6 . History malignancy within past five year exception successfully treat nonmetastatic basal cell squamous cell carcinoma skin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Chronic Pain</keyword>
	<keyword>This clinical trial compare immediate-release ( IR )</keyword>
	<keyword>oxycodone extended-release ( ER ) oxycodone</keyword>
	<keyword>management chronic pain</keyword>
</DOC>